A HNF4a-caGR fusion transcription factor as potential treatment for inflammatory liver diseases and liver cancer
The HNF4α-caGR fusion transcription factor is an innovative therapeutic protein designed to restore liver function and reduce inflammation in liver diseases and liver cancer by simultaneously activating key regulatory pathways.
Background:
Liver diseases and liver cancer often involve impaired function of hepatocyte nuclear factor 4α...
Published: 8/27/2026
|
Inventor(s): Hong Lu
Keywords(s): anticancer therapeutic, anti-inflammatory therapeutic, gene therapy, liver disease, sepsis, Technologies, tumor suppressor genes
Category(s): Campus > Upstate Medical University, Technology Classifications > Therapeutics and Vaccines
|